相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Signatures of Tumour and Its Microenvironment for Precise Quantitative Diagnosis of Oral Squamous Cell Carcinoma: An International Multi-Cohort Diagnostic Validation Study
Muy-Teck Teh et al.
CANCERS (2022)
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Saima Usman et al.
CANCERS (2021)
Carfilzomib enhances cisplatin-induced apoptosis in SK-N-BE(2)-M17 human neuroblastoma cells
Song- Lee et al.
SCIENTIFIC REPORTS (2019)
The changing therapeutic landscape of head and neck cancer
John D. Cramer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi et al.
CELL DEATH & DISEASE (2019)
Induction chemotherapy in head and neck cancers: Results and controversies
Max Gau et al.
ORAL ONCOLOGY (2019)
Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells
Chi-Neu Tsai et al.
SCIENTIFIC REPORTS (2019)
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Stefan Schmidt et al.
CLINICAL CANCER RESEARCH (2018)
Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma
Wei-Min Chang et al.
CANCER RESEARCH (2016)
Molecular mechanisms for synergistic effect of proteasome inhibitors with platinum-based therapy in solid tumors
Angel Chao et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2016)
Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas
Hong Ma et al.
ONCOTARGET (2016)
Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis
Muy-Teck Teh et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
From clinical trials to clinical practice: single-agent carfilzomib adverse events and their management in patients with relapsed and/or refractory multiple myeloma
David S. Siegel
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
分享论文
